Charlson Comorbidity Index (CCI)
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۱۲۰ • واحد: years
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–1
- Moderate Risk2–3
- High Risk4–5
- Very High Risk6–37
The Charlson Comorbidity Index (CCI) calculates predicting 10-year survival in patients with multiple comorbidities. Key inputs include age. Scores guide deprescribing high-risk medications, implementing multimodal fall-prevention plans, and cognitive support. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts 10-year survival in patients with multiple comorbidities. Uses 19 weighted comorbidity categories plus age adjustment to estimate mortality risk and guide clinical decision-making.
Clinical Indication
The Charlson Comorbidity Index (CCI) is indicated for bedside clinical practice to support Predicts 10-year survival in patients with multiple comorbidities. Uses 19 weighted comorbidity categories plus age adjustment to estimate mortality risk and guide clinical decision-making.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Older adults aged 65 years and older presenting with frailty syndromes, dementia, delirium, falls, and polypharmacy. Clinical application is indicated across Geriatric medicine wards, skilled nursing facilities, memory clinics, and outpatient geriatric care.
Limitations & Contraindications
Elderly patients routinely present with atypical disease manifestations, such as hypoactive delirium without fever in systemic bacteremia.
Clinical Pearls & Action Plan
Comprehensive geriatric assessment incorporating activities of daily living (ADLs) and Beers criteria medication review is essential. Guideline pearl: Helps guide treatment intensity and screening decisions based on life expectancy.
CCI Score = Sum of comorbidity points + Age adjustment points. 10-year survival = 0.983^(CCI × 0.9)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient age in years. Age adjustment: 0 points (<50), 1 point (50-59), 2 points (60-69), 3 points (70-79), 4 points (≥80)(years) |
| myocardial_infarction | string | Yes | History of myocardial infarction (1 point if present) |
| congestive_heart_failure | string | Yes | Congestive heart failure (1 point if present) |
| peripheral_vascular_disease | string | Yes | Peripheral vascular disease (1 point if present) |
| cerebrovascular_disease | string | Yes | Cerebrovascular accident or TIA (1 point if present) |
| dementia | string | Yes | Dementia (1 point if present) |
| chronic_pulmonary_disease | string | Yes | Chronic pulmonary disease (1 point if present) |
| connective_tissue_disease | string | Yes | Connective tissue disease (1 point if present) |
| peptic_ulcer_disease | string | Yes | Peptic ulcer disease (1 point if present) |
| liver_disease | string | Yes | Liver disease severity. Mild (1 point), Moderate-Severe (3 points), None (0 points). Mutually exclusive with diabetes categories. |
| diabetes | string | Yes | Diabetes severity. Uncomplicated (1 point), With end-organ damage (2 points), None (0 points). Mutually exclusive with liver disease categories. |
| hemiplegia | string | Yes | Hemiplegia (2 points if present) |
| moderate_severe_ckd | string | Yes | Moderate to severe chronic kidney disease (2 points if present) |
| localized_solid_tumor | string | Yes | Localized solid tumor (2 points if present) |
| leukemia | string | Yes | Leukemia (2 points if present) |
| lymphoma | string | Yes | Lymphoma (2 points if present) |
| metastatic_solid_tumor | string | Yes | Metastatic solid tumor (6 points if present) |
| aids | string | Yes | AIDS (6 points if present) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–1 | Low Risk | Minimal comorbidity burden |
| 2–3 | Moderate Risk | Moderate comorbidity burden |
| 4–5 | High Risk | Significant comorbidity burden |
| 6–37 | Very High Risk | Severe comorbidity burden |
Evidence-Based References (EBM)
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
- Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-51.
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-9.